DOLORES BENEDICTA NJOKU, M.D.
Psychiatric at Wolfe St, Baltimore, MD
License number
Maryland D46311
Category
Osteopathic Medicine
Type
Anesthesiology
License number
Maryland D46311
Category
Osteopathic Medicine
Type
Critical Care Medicine
License number
Maryland D46311
Category
Psychiatric
Type
Interventional Pain Medicine
Address
Address
600 N Wolfe St, Baltimore, MD 21287
Phone
(410) 955-6353
(410) 933-5474
(410) 933-5474
Personal information
See more information about DOLORES BENEDICTA NJOKU at radaris.comName
Address
Phone
1509 Ivy Hill Rd, Cockeysville, MD 21030
1509 Ivy Hill Rd, Cockeysville, MD 21030
7 Willwood Ct, Baltimore, MD 21209
7 Willard St, Baltimore, MD 21223
Professional information
See more information about DOLORES BENEDICTA NJOKU at trustoria.com
Director, The Fellowship In Pediatric Anesthesiology At Johns Hopkins Hospital
Director, The Fellowship In Pediatric Anesthesiology At Johns Hopkins Hospital
Position:
Associate Professor at Johns Hopkins University, Director, The Fellowship in Pediatric Anesthesiology at Johns Hopkins Hospital, Pediatric Anesthesiology, Pediatrics and Pathology at Johns Hopkins University
Location:
Baltimore, Maryland Area
Industry:
Research
Work:
Johns Hopkins University
since 2008
-
Associate Professor
Johns Hopkins Hospital
- Baltimore, MD since Jan 2007
-
Director, The Fellowship in Pediatric Anesthesiology
Johns Hopkins University
since Jan 1997
-
Pediatric Anesthesiology, Pediatrics and Pathology
National Institutes of Health
Jun 1994 - Apr 2002
-
Adjunct Investigator
Education:
University of Mississippi School of Medicine 1983 - 1987
MD
MD
Recognition Of Cyp2E1 Epitopes
Recognition Of Cyp2E1 Epitopes
US Patent:
2012004, Feb 16, 2012
Filed:
Feb 26, 2010
Appl. No.:
13/203402
Inventors:
Dolores Benedicta Njoku - Baltimore MD, US
Assignee:
THE JOHNS HOPKINS UNIVERSITY - Baltimore MD
International Classification:
G01N 33/566, C12N 9/02, C07H 21/00, C07K 14/47
US Classification:
435 792, 530326, 530300, 435189, 536 235, 536 232
Abstract:
A critical epitope of human cytochrome P4502E1 (CYP2E1) associated with the development of hepatic autoimmune disease, including methods and kits for diagnosis and prognosis using the critical epitope as a biomarker for hepatic autoimmune disease.